No abstract available
MeSH terms
-
Adenocarcinoma / drug therapy*
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
-
Carcinoma, Squamous Cell / drug therapy*
-
Carcinoma, Transitional Cell / drug therapy*
-
Combined Modality Therapy
-
Female
-
Humans
-
Male
-
Prognosis
-
Urinary Bladder Neoplasms / drug therapy*